FDA approves Teflaro for treatment of community-acquired bacterial pneumonia
Links shared publicly online about this topic.
- 763total visits
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia
View full resource at news-medical.net
Tags: Sore Throat, Strep Throat, Pneumonia, Bacterial Pneumonia, Drug, FDA, Forest Laboratories
Most Recently Shared on October 30, 2010 at 4:33 pm By:
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia: Forest Laboratories, Inc. announced ... http://bit.ly/ci6Cqx
Forest Announces FDA Approval Of Teflaro(TM) For The Treatment Of Community-Acquired Bacterial Pneumonia And ABSSSI
medicalnewstoday.com — “Forest Laboratories, Inc. (FRX) announced that Teflaro(TM) (ceftaroline fosamil), a broad-spectrum bactericidal cephalosporin with activity against both gram-positive and gram-negative microorgani” View full resource at medicalnewstoday.com
Most Recently Shared on November 2, 2010 at 1:05 pm By:
Forest Announces FDA Approval Of Teflaro(TM) For The Treatment Of Community-Acquired Bacterial Pneumonia And ABSSSI http://mnt.to/3LWT
FDA Approves Teflaro for Bacterial Infections
drugs.com — “Teflaro (ceftaroline fosamil) is used to treat acute bacterial skin and skin structure infections and community acquired bacterial pneumonia. Includes Teflaro side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 1, 2010 at 10:06 pm By:
FDA Approves Teflaro for Bacterial Infections: SILVER SPRING, Md., Oct. 29 /PRNewswire-USNewswire/ -- The U.S... http://bit.ly/b01YTn #drug
FDA Approves Teflaro for Bacterial Infections
drugs.com — “Teflaro (ceftaroline fosamil) is used to treat acute bacterial skin and skin structure infections and community acquired bacterial pneumonia. Includes Teflaro side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 1, 2010 at 9:49 pm By:
FDA Approves Teflaro for Bacterial Infections - http://bit.ly/bgEk13
Medical News: FDA Approves New Antibiotic for CABP and MRSA - in Infectious Disease, Pneumonia from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved ceftaroline fosamil (Teflaro), an injectable cephalosporin antibiotic to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and” View full resource at medpagetoday.com
Most Recently Shared on November 1, 2010 at 1:00 pm By:
FDA Approves New Antibiotic for CABP and MRSA - in Infectious Disease, Pneumonia from MedPage Today http://t.co/b2DDKEO via @AddThis
FDA Approves Teflaro For Bacterial Infections
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin a” View full resource at medicalnewstoday.com
Most Recently Shared on October 30, 2010 at 1:05 pm By:
FDA Approves Teflaro For Bacterial Infections http://mnt.to/3LTC #mrsa
Forest Laboratories Gets FDA Approval For Pneumonia Drug Teflora
rttnews.com — “Friday, drug maker Forest Laboratories Inc. (FRX), said the the U.S. Food and Drug Administration has approved Teflaro for the treatment of community-acquired bacterial pneumonia, and also for skin related infections.” View full resource at rttnews.com
Most Recently Shared on October 30, 2010 at 4:30 am By:
Forest Laboratories Gets FDA Approval For Pneumonia Drug Teflora: Friday, drug maker Forest Laboratories Inc. (FRX... http://bit.ly/divdGr
Tygacil gains indication for community-acquired bacterial pneumonia in adults - MPR
empr.com — “Tygacil (tigecycline, from Wyeth) has been FDA approved for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.” View full resource at empr.com
Most Recently Shared on March 25, 2009 at 2:47 pm By:
Tygacil gains indication for community-acquired bacterial pneumonia in adults: Tygacil (tigecycline, from Wyeth).. http://tinyurl.com/cgcl2n
Advertisement

